These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16269443)

  • 1. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease.
    Skipper L; Li Y; Bonnard C; Pavanni R; Yih Y; Chua E; Sung WK; Tan L; Wong MC; Tan EK; Liu J
    Hum Mol Genet; 2005 Dec; 14(23):3549-56. PubMed ID: 16269443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.
    Paisán-Ruíz C; Evans EW; Jain S; Xiromerisiou G; Gibbs JR; Eerola J; Gourbali V; Hellström O; Duckworth J; Papadimitriou A; Tienari PJ; Hadjigeorgiou GM; Singleton AB
    J Med Genet; 2006 Feb; 43(2):e9. PubMed ID: 16467219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.
    Sadhukhan T; Vishal M; Das G; Sharma A; Mukhopadhyay A; Das SK; Ray K; Ray J
    Dis Markers; 2012; 32(6):355-62. PubMed ID: 22684232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of linkage disequilibrium of LRRK2 across different races: implications for genetic association studies.
    Li H; Teo YY; Tan EK
    PLoS One; 2013; 8(9):e75041. PubMed ID: 24040382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease.
    Patra B; Parsian AJ; Racette BA; Zhao JH; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2009 Mar; 15(3):175-80. PubMed ID: 18752982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 P755L variant in sporadic Parkinson's disease.
    Tomiyama H; Mizuta I; Li Y; Funayama M; Yoshino H; Li L; Murata M; Yamamoto M; Kubo SI; Mizuno Y; Toda T; Hattori N
    J Hum Genet; 2008; 53(11-12):1012-1015. PubMed ID: 18923807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.
    Di Fonzo A; Wu-Chou YH; Lu CS; van Doeselaar M; Simons EJ; Rohé CF; Chang HC; Chen RS; Weng YH; Vanacore N; Breedveld GJ; Oostra BA; Bonifati V
    Neurogenetics; 2006 Jul; 7(3):133-8. PubMed ID: 16633828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
    Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
    Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.
    Hatano T; Funayama M; Kubo SI; Mata IF; Oji Y; Mori A; Zabetian CP; Waldherr SM; Yoshino H; Oyama G; Shimo Y; Fujimoto KI; Oshima H; Kunii Y; Yabe H; Mizuno Y; Hattori N
    Neurobiol Aging; 2014 Nov; 35(11):2656.e17-2656.e23. PubMed ID: 24973808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.
    Gopalai AA; Lim SY; Chua JY; Tey S; Lim TT; Mohamed Ibrahim N; Tan AH; Eow GB; Abdul Aziz Z; Puvanarajah SD; Viswanathan S; Looi I; Lim SK; Tan LP; Chong YB; Tan CT; Zhao Y; Tan EK; Ahmad-Annuar A
    Biomed Res Int; 2014; 2014():867321. PubMed ID: 25243190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
    Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
    Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.
    Tan EK; Zhao Y; Skipper L; Tan MG; Di Fonzo A; Sun L; Fook-Chong S; Tang S; Chua E; Yuen Y; Tan L; Pavanni R; Wong MC; Kolatkar P; Lu CS; Bonifati V; Liu JJ
    Hum Genet; 2007 Feb; 120(6):857-63. PubMed ID: 17019612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.
    Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG
    Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 and Parkinson's disease in Norway.
    Toft M; Haugarvoll K; Ross OA; Farrer MJ; Aasly JO
    Acta Neurol Scand Suppl; 2007; 187():72-5. PubMed ID: 17419834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
    Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
    Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.
    Dupré N; Rivière JB; Myers RH; Provencher P; Pourcher E; Emond F; Rouleau GA
    Can J Neurol Sci; 2007 Aug; 34(3):333-5. PubMed ID: 17803032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
    Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
    Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
    Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
    Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.